Prednisone/adalimumab/infliximabVarious toxicities and off label use of adalimumab and inflixiumab: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1699卷 / 1期

关键词：

D O I：

10.1007/s40278-018-45521-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：253 / 253

相关论文

共 50 条

[21] Adalimumab/golimumab/infliximabVarious toxicities: 9 case reports
Reactions Weekly, 2022, 1905 (1) : 18 - 18
[22] Adalimumab/etanercept/infliximabVarious toxicities: 13 case reports
Reactions Weekly, 2022, 1902 (1) : 20 - 20
[23] Adalimumab/etanercept/infliximabVarious toxicities: 5 case reports
Reactions Weekly, 2011, 1377 (1) : 6 - 6
[24] Adalimumab/etanercept/infliximabVarious toxicities: 12 case reports
Reactions Weekly, 2016, 1583 (1) : 38 - 38
[25] Adalimumab/azathioprine/infliximabVarious toxicities: 11 case reports
Reactions Weekly, 2014, 1524 (1) : 15 - 15
[26] Adalimumab/etanercept/infliximabVarious toxicities: 9 case reports
Reactions Weekly, 2018, 1698 (1) : 22 - 22
[27] Adalimumab/etanercept/infliximabVarious toxicities: 41 case reports
Reactions Weekly, 2010, 1297 (1) : 7 - 7
[28] Adalimumab/etanercept/infliximabVarious toxicities: 6 case reports
Reactions Weekly, 2021, 1853 (1) : 19 - 19
[29] Adalimumab/etanercept/infliximabVarious toxicities: 3 case reports
Reactions Weekly, 2024, 2027 (1) : 20 - 20
[30] Adalimumab/infliximabVarious toxicities and lack of efficacy: 6 case reports
Reactions Weekly, 2021, 1859 (1) : 15 - 15

← 1 2 3 4 5 →